A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor.
Erythropoietin induces dimerization of the erythropoietin receptor on the surface of erythroid progenitor cells, promoting the differentiation of these cells into mature red blood cells. To facilitate screening of large chemical collections for identification of compounds that can dimerize erythropoietin receptor, we have developed a novel, high-throughput in vitro assay to detect compounds that can cause dimerization of the erythropoietin receptor in solution. To develop this assay, amino acid sequences corresponding to the extracellular domain of erythropoietin receptor were expressed in Escherichia coli as erythropoietin-binding protein (rEBP). A modified version of this protein ((33)P-rEBP) containing a protein kinase A substrate site incorporated into the rEBP was also expressed in E. coli and labeled in vitro using protein kinase A and ¿gamma-(33)PATP. An erythropoietin mimetic peptide (EMP-1), that induces dimerization of rEBP in solution was used to demonstrate dimerization of (33)P-rEBP and rEBP in a 96-well microtiter plate format. EMP-1 induced dimerization of rEBP in this assay with an EC(50) of approximately 245 nM and had a maximal effect at 0.5-2 microM and required the presence of rEBP immobilized on the plate capable of binding EMP-1. EMP-1-induced dimerization of (33)P-rEBP and rEBP was reversed by excess unlabeled rEBP and was not masked by complex mixtures such as whole cell fungal extracts. These data demonstrate the ability of (33)P-rEBP to dimerize with rEBP in vitro in a format that is fully compatible with high-throughput screening.
Biazzo
D E
DE
Merck Research Laboratories, Rahway, New Jersey 07065-0900, USA.
Motamedi
H
H
Mark
D F
DF
Qureshi
S A
SA
D019281:Dimerization; D004921:Erythropoietin / Q000494:pharmacology; D018716:Molecular Mimicry; D010446:Peptide Fragments / Q000819:agonists / Q000235:genetics; D010456:Peptides, Cyclic / Q000494:pharmacology; D017467:Receptors, Erythropoietin / Q000819:agonists* / Q000235:genetics; D011994:Recombinant Proteins / Q000819:agonists; D013678:Technology, Pharmaceutical / Q000379:methods*
C099963:EPO mimetic peptide 1; D010446:Peptide Fragments; D010456:Peptides, Cyclic; D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; C117514:erythropoietin receptor (1-225); D004921:Erythropoietin